Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma
To access this article, please choose from the options below
PII: S0145-2126(09)00060-5
doi:10.1016/j.leukres.2009.01.039
© 2009 Elsevier Ltd. All rights reserved.
